COBO Technologies is a fast-growing start-up company based in Copenhagen, Denmark, that specializes in products and services for Quality Control (QC) of CRISPR modified cells and animals. The team behind COBO comes from senior positions in science, commercial and operation, with more than 10 years experience in the CRISPR field. Within the last 5 years, the CRISPR field has developed from more than 100 publications per year to now more than 5,000 publications per year and the number of ongoing clinical trials using a CRISPR tool is now more than 60. In 2020 two CRISPR scientists received the Nobel Prize in Chemistry for their CRISPR inventions, proving that this is a fast-growing field which is now moving from research to clinics. In consequence, there is a need for platforms that can support efficient QC of CRISPR cells. In more general terms, there is a need to understand what are the safety effects of altering DNA with CRISPR — hitting the right target gene, checking how efficient the DNA change is, and investigating other DNA changes that were not expected. Most of the solutions offered today for cell/DNA analysis are not developed specifically for CRISPR applications. They are expensive, lack sensitivity and are time-consuming and they are done by service companies with no/or little knowledge about CRISPR. Based on our experience from the CRISPR field and feedback from our network in the EU and US, we have developed proprietary platforms that can support the current needs for QC of CRISPR cells. Including both proven reagents for sample preparation, cell analysis and bioinformatics, this is the first full-package solution developed specifically for CRISPR clients. In addition, it combines low cost, high sensitivity and fast delivery time - 3 factors essential for our clients. We have used the past year to build up a scalable operation in Denmark in a low-risk setup and are now ready to speed up the growth first in the EU and then later 2021 in the US. In addition, we will also start the initial preparation of our first development project for a clinical application at the end of 2021. Since the start 2018, COBO has supported more than 15 clients in both EU and US, including leading pharma companies and some of the leading universities in the world. We have developed unique platforms, we have clients every week, we have the network and we have the skills to be a major player in the global CRISPR field and be part of the development of future CRISPR Medicine to treat genetic diseases. As of today, COBO Technologies is backed by an angel investor.

For a quick intro pls see: https://drive.google.com/file/d/168TTZsNef43Awmxz3iALMhx2saVk5ihe/view?usp=sharing The problem & the idea Data may be the driver for change, improvement and understanding, in many sectors, amongst these also healthcare. Patient data is an important creator of knowledge both on an individual level but also on a group, regional or country level. On an individual level, patient data may support and build the clinical decisions, it may provide more efficient treatment, both in regard to time and economy and secure that knowledge about the individual is transferred fast and unbiased to the healthcare staff. For the patient, sharing of his/her data will secure a better understanding of the needs and support better diagnosis and treatment. Patient data are collected and noticed in some form in most countries, either on paper or electronically. Many countries have some sort of an electronic patient journal, either on a country level, regionally or locally. However, many countries also still use pen & paper. This challenges the storage and continuity of data collection and transfer. Patient data records in electronic form reduces the risk of losing valuable data but also allows the data to be shared if needed. The acknowledgement of the importance on several levels of having patient data and the absence of a central, regional or local electronic patient data recording system in Sub-saharan African countries (the target region) initiated the idea of looking at how it would be possible to collect and make patient data readily available for treatment, benefitting both patient and caregiver, and in a bigger perspective, for research and strategic healthcare initiative planning. During small initial market and possibility investigations the idea of creating a patient owned electronic healthdata journal app arose. Mobiletechnology is both greatly advantaged and outspread in the target region and the number of mobile consumers are increasing every year. It was and is anticipated, that the possibility of having a central system is, due to structural and financial reasons, not a possibility but to empower the patient with the ownership of own data through an app seemed a possibility. It is important to underline that data must be generated from the healthcare provider and then fed into the patientjournal at the site of the consultation. The idea is to have the most relevant data collected and stored in the app, ie. medication, allergies, blood type, diagnosis and immunizations. The data that will go into the app is transferred from a healthcare provider at the site of the healthcare visit, eg a clinique, hospital, other. That means that the healthcare provider must have access to a tablet or smartphone containing the healthcare provider app which connects to the patients healthcare data app at the visit. Also any healthcare provider with the app will followingly get access to the data from the patient by connecting (and by being given access by the patient) to get patients healthdata app. So, in summary the basic idea is to provide all citizens with a tool that will help them keep track of their most important healthcare related data including completed and planned treatments, diagnosis, tests, allergies etc. The idea is further that the data is owned by the citizens/patients, and not by the non-existing national or any hospital specific system. Upon each contact with the healthcare personnel the patient's information is updated by the healthcare personnel (e.g. symptoms, diagnosis, tests, treatment, next visit etc.) The basic idea/assumption is that no national healthcare system will be developed in near or short-term future, and that a personally owned "electronic patient journal" can have a significant positive impact on the quality of treatments because of a more complete picture of the patient is available at the time, when a diagnosis and treatment is to be decided.

NUKIGA faciliterer værdiskabende partnerskaber mellem iværksættere, virksomheder og studerende. Vi udvikler et virtuelt væksthus, og vi skaber ny viden om Grønland i Danmark gennem en række kulturelle projekter. Dialog og partnerskaber opstår, når mennesker mødes enten fysisk eller online. Vores arbejde er derfor funderet i både fysiske såvel som online events og projekter.

Putting all educated masseuses together in Denmark on the homepage www.zency.dk. We offer quality treatments by trained masseurs specially adapted to the body. The ambition of our therapists is to create the feeling of a well-functioning body with the surplus to, achieve the maximum in your life, every day. Visit us here: https://zency.dk/

MAAB Group is an investment and trading company specialised in commercialising innovative healthcare products internationally. The company was founded by pharmaceutical industry veterans in 2011 and was originally incorporated in Hong Kong, China. Today, the company is headquartered in New Zealand, with operations in mainland China, the UK, and Denmark. ​

Coaching can transform a persons career and well being, that's why Coachendo democratises career coaching by combining AI technology and human coaches in one solution. Coachendo offers it's service to companies that want to invest in their teams and empower them with personalised development plans that fit their values and skillset. By that, companies can increase performance, decrease stress levels and increase retention rate. This is a reflection of how people in the organisation benefits from this service.

Unfair Advantage Oy - Academy of Practical Experience provides international students the opportunity to get the elusive experience needed before they get their first job. We are like an intersection between being a uni culture and working with real-life projects so our trainees can get experience in their desired field while building up their confidence and market value. Learn more at https://startupintern.strikingly.com/ The main goal of Unfair Advantage Oy is to promote social interaction and a solution to social loneliness and psychographic isolating behavioral patterns that we see become more and more common in the digital world of today. We believe that humans need to connect in order to survive, and we are helping connect humanity. Want to meet us in person? Drop by our weekly and famous Cafe Lingua event that our company partners with --> https://cafelingua.smartfrends.com/

With over 2 million unique visitors per month, Moneezy.com quickly became one of the world’s largest online loan comparison services. Moneezy enables people to safely and in just few click compare numerous loan options so they can select the best one for them. We firmly believe in transparency in the financial sector and are dedicated to making private financing accessible to all people. As a fast-growing startup we're looking to expand and are on the outlook for new additions to the team!

We are a rapidly growing startup soon launching our innovative product and are looking for a passionate and dedicated co-founder to join us on the journey. If you have experience in advertising strategies, a burning interest in being part of shaping the future of gloves and skinhealth, and are ready to contribute your expertise and enthusiasm, then you are the one we are looking for! We believe in creating meaningful changes and are seeking a co-founder who shares our vision and is ready to tackle the challenges that come with building and growing a successful company. If you are ready to take on this exciting opportunity, please contact us to discuss further. Problem: Despite billions of people using gloves daily, few have reflected on how hand sweat and materials like rubber can affect their career choices and quality of life. 1. Skin diseases affect almost one-third of the world's population. 2. For over 137 years has moisture accumulation inside gloves been a globally unresolved issue costing the society billions and leading to decreased quality of life and career changes. 3. In the US alone, the willingness to invest in symptom relief for hand eczema amounts to 40 billion dollars. Solution: Unlike products on the market that absorb moisture, our product absorbs and transports away hand sweat to keep hands soft and free from moisture and irritation, no matter how long you wear them. Uniqueness compared to cotton gloves: Cotton gloves cannot transport sweat away, as cotton only acts as an absorbing surface, leading to damp hands. Additionally, cotton gloves are used as disposable items and require 50,000 liters of water to produce one kilogram of cotton. Function and material: The DRYE inner glove is made of an exclusive material combination consisting of 55% Lyocell and 45% Polypropylene. This technology is deliberately designed to minimize irritation while enabling optimal moisture transport, enhancing user comfort and effectiveness. Moisture transport technology: Our advanced technology effectively absorbs moisture from the inside of the glove and transports it to the outside of the fabric. By keeping hands dry, our glove not only improves the user experience but also enhances the quality of life for billions of people suffering from hand-related issues.

Statistics show that approximately 90 percent of paper receipts end up in the trash can. Most people part ways with their receipts shortly after collection, and many others can’t remember where they kept it if they did at all. Paper receipts contain BPA or Bisphenol A, a plastic component which is harmful for the health and cannot be recycle, in addition to this the environmental impact of its production, where in Europe, over 13 million trees and 17 billion gallons of water are consumed each year in the creation of paper receipts, generating 2.500 billion tons of waste and 4 billion tons of CO2. ClowID is an innovative solution, a full stack Customer engagement platform that connects merchants and end customers through Smart Receipts. For final consumer a free app to save receipts and warranties in one place, without disclosing personal information, no email, no phone, no name, while providing more personalised experience. For merchants one click installation software with no initial development costs, to reduce environmental impact and costs while increasing their customer insight, improving digital transactions, in-person customer experiences, increasing customer engagement and loyalty. We have a golden opportunity to make a positive impact on our planet, the future is now!

Åpenhet is a Norwegian GovTech company based in Oslo and Paris. We specialize in good governance & data driven policy making. We provide services to public administrations and organisations across Europe. Our primary goal is to foster international cooperation through knowledge and data sharing. We are growing our team.

Decision Beacon is building the next generation online business intelligence experience. The aim is to empower the decision process in SMEs by providing the required reports through a no-programming-no-tech-required online platform. Founded by veteran data warehouse/business intelligence professionals, with the belief that data driven decision support should be available to all professionally run businesses, regardless of size and IT-budget.

Proxi Biotech, an early stage spin-off from Staten Serum Institute, has developed the BID Technology for detoxification of bacterial toxins to be used as next generation vaccine antigens. BID Technology replaces the conventional cross-reacting agents in the development of new antigens for toxoid-based vaccines that are highly needed to overcome the challenges of antimicrobial resistance.

Wirepas Mesh enables wireless IoT networking at massive scale. It is a de-centralized IoT network protocol that can be used to connect, locate and identify lights, sensors, beacons, assets, machines and meters in cities, buildings, industry, logistics and energy – with unprecedented scale, density, flexibility and reliability. It can be used on any radio hardware and on any frequency band. Wirepas has its headquarters in Tampere, Finland and offices in Australia, France, Germany, India, South Korea, Taiwan, the UK and the United States.

Data in Chains is a Helsinki-based software development company specializing in Blockchain based solutions for Streamr (www.streamr.com), a leading pioneer blockchain company from Switzerland. The first of its kind in Finland, we are delicately building a decentralized solution for a real-time data sales network. Beyond product development, we are also running Ethereum Consulting services and customer projects for those businesses that wish to be a part of this revolution.